UK markets closed

Formosa Pharmaceuticals, Inc. (6838.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
55.30+2.10 (+3.95%)
At close: 02:59PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
158,972
31,172
1,315
28,529
0
Cost of revenue
19,800
3,825
982
267
0
Gross profit
139,172
27,347
333
28,262
0
Operating expenses
Research development
275,538
270,181
356,473
387,617
216,289
Selling general and administrative
44,062
40,202
25,529
20,653
17,312
Total operating expenses
319,600
310,383
382,002
408,270
233,601
Operating income or loss
-180,428
-283,036
-381,669
-380,008
-233,601
Interest expense
4,417
4,308
992
2,207
102
Income before tax
-216,663
-300,065
-406,593
-398,422
-220,150
Income tax expense
40,996
21,862
-424
2,397
-420
Income from continuing operations
-257,659
-321,927
-406,169
-400,819
-219,730
Net income
-257,741
-321,956
-406,272
-400,883
-219,659
Net income available to common shareholders
-257,741
-321,956
-406,272
-400,883
-219,659
Basic EPS
-3.01
-2.59
-3.86
-4.21
-3.01
Diluted EPS
-3.01
-2.59
-3.86
-4.21
-3.01
Basic average shares
122,297
124,089
108,255
95,212
73,193
Diluted average shares
134,142
124,089
108,255
95,212
73,193